Skip Nav Destination
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma
Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia
Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up study
Issue Archive
Table of Contents
BLOOD FLASHBACK
INSIDE BLOOD COMMENTARIES
BLOOD SPOTLIGHT
REVIEW ARTICLE
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma
Clinical Trials & Observations
Meletios A. Dimopoulos,Antonio Palumbo,Paolo Corradini,Michele Cavo,Michel Delforge,Francesco Di Raimondo,Katja C. Weisel,Albert Oriol,Markus Hansson,Angelo Vacca,María Jesús Blanchard,Hartmut Goldschmidt,Chantal Doyen,Martin Kaiser,Mario Petrini,Pekka Anttila,Anna Maria Cafro,Reinier Raymakers,Jesus San-Miguel,Felipe de Arriba,Stefan Knop,Christoph Röllig,Enrique M. Ocio,Gareth Morgan,Neil Miller,Mathew Simcock,Teresa Peluso,Jennifer Herring,Lars Sternas,Mohamed H. Zaki,Philippe Moreau
Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia
Clinical Trials & Observations
Brief Report
Nicholas J. Short,Elias Jabbour,Koji Sasaki,Keyur Patel,Susan M. O’Brien,Jorge E. Cortes,Rebecca Garris,Ghayas C. Issa,Guillermo Garcia-Manero,Rajyalakshmi Luthra,Deborah Thomas,Hagop Kantarjian,Farhad Ravandi
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies
Marianna Sabatino,Jinhui Hu,Michele Sommariva,Sanjivan Gautam,Vicki Fellowes,James D. Hocker,Sean Dougherty,Haiying Qin,Christopher A. Klebanoff,Terry J. Fry,Ronald E. Gress,James N. Kochenderfer,David F. Stroncek,Yun Ji,Luca Gattinoni
LYMPHOID NEOPLASIA
Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration
Marta Pasikowska,Elisabeth Walsby,Benedetta Apollonio,Kirsty Cuthill,Elizabeth Phillips,Eve Coulter,Maria Serena Longhi,Yun Ma,Deborah Yallop,Linda D. Barber,Piers Patten,Chris Fegan,Alan G. Ramsay,Chris Pepper,Stephen Devereux,Andrea G. S. Buggins
Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia
Rachel Thijssen,Johanna ter Burg,Brett Garrick,Gregor G. W. van Bochove,Jennifer R. Brown,Stacey M. Fernandes,María Solé Rodríguez,Jean-Marie Michot,Michael Hallek,Barbara Eichhorst,Hans Christian Reinhardt,Johanna Bendell,Ingrid A. M. Derks,Roel J. W. van Kampen,Kristen Hege,Marie José Kersten,Torsten Trowe,Ellen H. Filvaroff,Eric Eldering,Arnon P. Kater
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up study
Clinical Trials & Observations
Tilmann Bochtler,Ute Hegenbart,Christina Kunz,Axel Benner,Christoph Kimmich,Anja Seckinger,Dirk Hose,Hartmut Goldschmidt,Martin Granzow,Peter Dreger,Anthony D. Ho,Anna Jauch,Stefan O. Schönland
BLOOD WORK
ERRATA
-
Cover Image
Cover Image
The confocal image shows CD4+ T cells forming enhanced F-actin (in red) immunological synapse interactions with chronic lymphocytic leukemia (CLL) cells (in blue). Extracellular vesicles released from CD40/IL-4–stimulated CLL cells confer this altered functional property to autologous CD4+ T cells. The cover figure is derived from Figure 4A in the article by Smallwood et al on page 542.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals